Pramana
Pramana is transforming digital pathology with its hardware-software co-designed whole slide imaging (WSI) systems. Their Spectral family of scanners offers autonomous operation, modularity for scalability, and integrated AI capabilities for real-time analysis during scanning. The company aims to bring fully autonomous systems to pathology labs, enabling AI-enabled workflows and improving patient outcomes. Pramana's approach addresses challenges in traditional pathology, such as manual quality control and scanner underutilization. They have a portfolio of granted U.S. patents and partner with leading healthcare organizations.
Pramana
Pramana is transforming digital pathology with its hardware-software co-designed whole slide imaging (WSI) systems. Their Spectral family of scanners offers autonomous operation, modularity for scalability, and integrated AI capabilities for real-time analysis during scanning. The company aims to bring fully autonomous systems to pathology labs, enabling AI-enabled workflows and improving patient outcomes. Pramana's approach addresses challenges in traditional pathology, such as manual quality control and scanner underutilization. They have a portfolio of granted U.S. patents and partner with leading healthcare organizations.
TL;DR
Sector: Digital pathology — whole slide imaging hardware + software
Founded: 2021
Headquarters: Cambridge, MA
Product: Spectral family of autonomous, modular whole-slide scanners with edge AI and inline QA
Employees: 164
Known funding: Series A (Jan 2022); total reported funding $30,000,000 USD
Company Overview
Problem Domain
Digital pathology — challenges in manual quality control, underutilized scanners, and integrating AI into pathology workflows.
Founded
2021
Industry
Healthcare / Digital Pathology
Funding Track Record
Investor Signal
“Series A led by Matrix Capital Management”